Fuller & Thaler Asset Management’s Evolent Health EVH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $430K | Sell |
38,200
-8,740
| -19% | -$98.4K | ﹤0.01% | 442 |
|
|
2025
Q1 | $445K | Buy |
+46,940
| New | +$445K | ﹤0.01% | 451 |
|
|
2024
Q4 | – | Sell |
-1,516,544
| Closed | -$42.9M | – | 620 |
|
|
2024
Q3 | $42.9M | Buy |
1,516,544
+229,128
| +18% | +$6.48M | 0.17% | 193 |
|
|
2024
Q2 | $24.6M | Buy |
1,287,416
+234,897
| +22% | +$4.49M | 0.11% | 238 |
|
|
2024
Q1 | $34.5M | Buy |
1,052,519
+295,405
| +39% | +$9.69M | 0.15% | 178 |
|
|
2023
Q4 | $25M | Buy |
757,114
+79,754
| +12% | +$2.63M | 0.13% | 179 |
|
|
2023
Q3 | $18.4M | Buy |
677,360
+51,169
| +8% | +$1.39M | 0.11% | 190 |
|
|
2023
Q2 | $19M | Buy |
626,191
+65,296
| +12% | +$1.98M | 0.11% | 188 |
|
|
2023
Q1 | $18.2M | Buy |
560,895
+39,456
| +8% | +$1.28M | 0.1% | 183 |
|
|
2022
Q4 | $14.6M | Buy |
521,439
+81
| +0% | +$2.27K | 0.09% | 181 |
|
|
2022
Q3 | $18.7M | Buy |
521,358
+1,949
| +0.4% | +$70K | 0.13% | 163 |
|
|
2022
Q2 | $16M | Buy |
519,409
+20,182
| +4% | +$620K | 0.11% | 178 |
|
|
2022
Q1 | $16.1M | Buy |
499,227
+497,140
| +23,821% | +$16.1M | 0.1% | 185 |
|
|
2021
Q4 | $58K | Hold |
2,087
| – | – | ﹤0.01% | 461 |
|
|
2021
Q3 | $65K | Sell |
2,087
-188
| -8% | -$5.86K | ﹤0.01% | 446 |
|
|
2021
Q2 | $48K | Sell |
2,275
-666,982
| -100% | -$14.1M | ﹤0.01% | 449 |
|
|
2021
Q1 | $13.5M | Buy |
669,257
+11,117
| +2% | +$225K | 0.1% | 190 |
|
|
2020
Q4 | $10.6M | Buy |
658,140
+10,551
| +2% | +$169K | 0.1% | 196 |
|
|
2020
Q3 | $8.04M | Buy |
+647,589
| New | +$8.04M | 0.1% | 191 |
|